Skip to content
March 13, 2024

Equity.Guru

Investment information for the new generation

Search

medical cannabis

Avicanna Inc. (AVCN.TO) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, announced today that Shoppers Drug Mart (Shoppers) has selected Avicanna as its…
A Fundamental Problem The opioid crisis has spread like an epidemic across North America. Between January 2016 and March 2019, an estimated 12,800 Canadians died from apparent opioid-related overdoses…
Filament Health Corp. (FH.NE) (“Filament”) announced today that it will be participating in three conferences throughout December 2021. These conferences include the Horizons: Perspectives on Psychedelics Conference, H.C. Wainwright 2nd…
Aurora Cannabis (ACB.T) announced on Tuesday that it will be shutting down its Aurora Polaris facility in Edmonton, Alberta. Furthermore, the Company has stated that approximately 12% of its…
Aurora Germany GmbH, a subsidiary of Aurora Cannabis (ACB.N), has successfully delivered their initial shipment of cannabis to France for their medical cannabis pilot program, set to begin serving…
Jushi Holdings (JUSH.C) closed its acquisition of Ohio-based cultivators, OhiGrow and Ohio Green Grow, for $5 million in cash, including a 10,000 square foot facility and 1.35 acres of…
Tilray (TLRY.T) announced that their wholly-owned German subsidiary Aphria RX GmbH has completed the first successful harvest of medical cannabis cultivated in Germany. The cannabis was delivered to German…
Khiron Life Sciences (KHRN.V) made its first sale of medical cannabis product in Brazil, according to a press release.   South America is generally cannabis friendly. There are a…
Khiron Life Sciences (KHRN.V) announced today that it has opened its first Zerenia™ clinic outside of Columbia, in Lima, Peru. “I am pleased to announce the first expansion of…
Tetra Bio-Pharma (TBP.T) announced today that Health Canada has accepted the Company’s New Drug Submission (NDS) for REDUVO™ and has formally entered the final review phase in the drug…